EcoDrugPlus

Voltage-Dependent L-Type Calcium Channel Subunit Beta-1-Like

Ensembl ID : ENSCSEG00000009867
Gene Symbol: LOC103392742
3 Cross references
210 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Beta-3

Ensembl ID : ENSCSEG00000020971
Gene Symbol: LOC103385411
3 Cross references
203 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSCSEG00000016780
Gene Symbol: LOC103393793
3 Cross references
168 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-4 Subunit-Like

Ensembl ID : ENSCSEG00000012533
Gene Symbol: LOC103392901
3 Cross references
192 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-6 Subunit-Like

Ensembl ID : ENSCSEG00000016751
Gene Symbol: LOC103393794
3 Cross references
181 Possible Orthologues:

Voltage-Dependent Calcium Channel Subunit Alpha-2/delta-1-Like

Ensembl ID : ENSCSEG00000008500
Gene Symbol: LOC103382776
3 Cross references
230 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSCSEG00000014252
Gene Symbol: XDH
3 Cross references
212 Possible Orthologues:

Ensembl ID : ENSCSEG00000004902
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSCSEG00000020539
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSCSEG00000008875
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSCSEG00000002718
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSCSEG00000020049
Gene Symbol: -
Cross references: -
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).